Back | Next |
home / stock / amgn / amgn message board
Subject | By | Source | When |
---|---|---|---|
$AMGN 4Q18 CC slides: | DewDiligence | investorshub | 01/29/2019 9:18:46 PM |
News: $AMGN deCODE Publishes the First Full Resolution | whytestocks | investorshub | 01/24/2019 7:51:26 PM |
News: $AMGN European Commission Approves BLINCYTO® (blinatumomab) In | whytestocks | investorshub | 01/22/2019 4:11:23 PM |
We visited the $AMGN booth at AHA this | north40000 | investorshub | 11/14/2018 8:32:24 PM |
$AMGN 3Q18 items | DewDiligence | investorshub | 10/30/2018 10:14:59 PM |
$24 is erroneous, should be $9 co-pay for | north40000 | investorshub | 10/22/2018 5:08:33 AM |
AMGN,$ NVS launch Humira biosimilars in Europe, pursuant | DewDiligence | investorshub | 10/16/2018 3:24:34 PM |
AMRN, $AMGN mentioned here: | north40000 | investorshub | 09/24/2018 5:41:11 PM |
$AMGN 2Q18 CC slides: | DewDiligence | investorshub | 07/26/2018 8:58:00 PM |
$AMGN and 3 Drug and Biotech Stocks Awaiting | BottomBounce | investorshub | 07/13/2018 2:10:13 PM |
$AMGN completes $10B buyback via tender offer for | DewDiligence | investorshub | 03/06/2018 4:47:49 PM |
$AMGN 4Q17 CC slides: | DewDiligence | investorshub | 02/01/2018 10:00:31 PM |
Head And Shoulder Pattern Formation On Amgen, Inc. | ITMS | investorshub | 12/27/2017 5:40:23 PM |
You are doing an excellent job...... following u | winner06 | investorshub | 11/21/2017 3:02:43 AM |
This Biotech Stock Struggles To Hold Key Level | ITMS | investorshub | 11/20/2017 5:53:05 PM |
$AMGN 3Q17 CC slides: | DewDiligence | investorshub | 10/25/2017 8:24:33 PM |
https://seekingalpha.com/article/4107923-amgen-allergan-avastin-biosimilar-appro | Inoviorulez | investorshub | 09/19/2017 10:49:25 PM |
https://seekingalpha.com/article/4092782-amgen-looks-enhance-cholesterol-drug | Inoviorulez | investorshub | 07/31/2017 9:45:49 PM |
$AMGN 2Q17 CC slides: | DewDiligence | investorshub | 07/25/2017 8:39:58 PM |
https://seekingalpha.com/article/4089618-amgen-novartis-first-mover-advantage-mu | Inoviorulez | investorshub | 07/23/2017 6:28:01 AM |
News, Short Squeeze, Breakout and More Instantly...
2024-07-18 10:30:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-07-15 07:58:00 ET Can a biotechnology company pay a generous dividend in 2024? The answer is definitely yes, as Amgen (NASDAQ: AMGN) is evidently unafraid to reward its loyal shareholders with quarterly cash payments. Just as importantly, Amgen is a recent revenue growe...
2024-07-14 06:30:00 ET Income investors don't have to settle for dividends that tread water. There are plenty of stocks to buy that offer growing dividends and are poised to keep the momentum going along with attractive dividend yields . Three Motley Fool contributors think they've ...